Evidence map›Paper›PMID 23168910›Full record

ArticleMolecular carcinogenesis2014

Evidence for possible non-canonical pathway(s) driven early-onset colorectal cancer in India.

Ratheesh Raman, Viswakalyan Kotapalli, Raju Adduri, Swarnalata Gowrishankar, Leena Bashyam, Ajay Chaudhary, Mohana Vamsy, Sujith Patnaik, Mukta Srinivasulu, Regulagadda Sastry and 6 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Molecular carcinogenesis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Early Onset Colorectal Cancer: Molecular Underpinnings Accelerating Occurrence.Cellular and molecular gastroenterology and hepatology · 2025
    Review
  6. Article
  7. Article
  8. Molecular genetics of early-onset colorectal cancer.World journal of biological chemistry · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Cancers · 2020
    Article
  15. CaJournal of molecular medicine (Berlin, Germany) · 2018
    Article
  16. Article
  17. Association of HPV with genetic and epigenetic alterations in colorectal adenocarcinoma from Indian population.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  18. Microsatellite instability and promoter hypermethylation in colorectal cancer in India.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  19. Rectal cancer in young Indians--are these cancers different compared to their older counterparts?Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Ratheesh RamanLaboratory of Molecular Oncology, Centre for DNA Fingerprinting and Diagnostics (CDFD), Nampally, Hyderabad, India.
Viswakalyan Kotapalli
Raju Adduri
Swarnalata Gowrishankar
Leena Bashyam
Ajay Chaudhary
Mohana Vamsy
Sujith Patnaik
Mukta Srinivasulu
Regulagadda Sastry
Subramanyeshwar Rao
Anjayneyulu Vasala
NarasimhaRaju Kalidindi
Jonathan Pollack
Sudha Murthy
Murali Bashyam
Centre for DNA Fingerprinting and Diagnostics · INBasavatarakam Indo American Cancer Hospital and Research Institute · INMNJ Institute Of Oncology and Regional Cancer Centre · INApollo Hospitals · INNizam's Institute of Medical Sciences · INStanford Medicine · US

Funding

Gene Amplification and Deletion in Pancreatic CancerR01CA112016 · NCI · STANFORD UNIVERSITY · PI POLLACK, JONATHAN R · 2006 to 2010
$1.4M
Molecular Characterization of Sporadic Colorectal Cancer in the Young from IndiaR03TW007963 · FIC · STANFORD UNIVERSITY · PI POLLACK, JONATHAN R · 2008 to 2010
$105k
FIC NIH HHS R03 TW007963FIC NIH HHS TW007963NCI NIH HHS CA112016NCI NIH HHS R01 CA112016
6 · The paper itself

Abstract

Two genetic instability pathways viz. chromosomal instability, driven primarily by APC mutation induced deregulated Wnt signaling, and microsatellite instability (MSI) caused by mismatch repair (MMR) inactivation, together account for >90% of late-onset colorectal cancer (CRC). Our understanding of early-onset sporadic CRC is however comparatively limited. In addition, most seminal studies have been performed in the western population and analyses of tumorigenesis pathway(s) causing CRC in developing nations have been rare. We performed a comparative analysis of early and late-onset CRC from India with respect to common genetic aberrations including Wnt, KRAS, and p53 (constituting the classical CRC progression sequence) in addition to MSI. Our results revealed the absence of Wnt and MSI in a significant proportion of early-onset as against late-onset CRC in India. In addition, KRAS mutation frequency was significantly lower in early-onset CRC indicating that a significant proportion of CRC in India may follow tumorigenesis pathways distinct from the classical CRC progression sequence. Our study has therefore revealed the possible existence of non-canonical tumorigenesis pathways in early-onset CRC in India.

Indexed as

Microsatellite InstabilityAdenocarcinomaAdultAgedCase-Control StudiesCell Transformation, NeoplasticColorectal NeoplasmsEarly DiagnosisFemaleFollow-Up StudiesHumansImmunoenzyme TechniquesIndiaMaleMiddle AgedMutationKRAS protein, humanProto-Oncogene ProteinsProto-Oncogene Proteins p21(ras)ras ProteinsWnt ProteinsAPCcolorectal cancerKRASMSIp53Wnt signaling

Identifiers

PMID23168910
PMCPMC3597761
OpenAlexW1560378429

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.